Studies PET/CT technology of molecular imaging that allows you to obtain detailed information on the metabolic activity of the body to support the diagnosis, staging and monitoring of different diseases.
PET/CT combines two imaging technologies to observe both the structure and metabolic activity of the organism in a single study.
Through the use of radiopharmaceuticals specific, it allows you to identify changes that may be relevant to the diagnosis, staging and monitoring of different diseases.
In the Center of Nuclear Molecular Medicine we have specialized technology and different radiopharmaceuticals that allow you to choose the suitable study according to the medical indication.
Each radiopharmaceutical allows you to study specific processes of the organism. In the Center we conduct studies on PET/CT FAN, FDG pet and PSMA, selected according to the medical indication and the characteristics of each patient.
Study of molecular imaging that is used in the evaluation of oncology and the follow-up of different types of cancer.
The PET/CT FAN is a specialized study mainly used in the evaluation of neuroendocrine tumors.
Allows you to identify lesions with specific receptors and to obtain information about its location and extent, to support the medical evaluation and follow-up of the disease.
Evaluation of neuroendocrine tumors.
The presence and distribution of lesions with specific receptors.
The PET/CT FDG is a study of molecular imaging that allows to assess the metabolic activity of the tissues.
It is used in different types of cancer and provides information for the evaluation, staging, treatment response, and follow-up of the disease.
Evaluation and monitoring of different oncological diseases.
Areas of increased metabolic activity and its distribution in the body.
The PET/CT PSMA is a specialized study aimed primarily to the evaluation of prostate cancer.
Allows you to identify injuries associated with the expression of PSMA and to obtain information on the location and extent of the disease, contributing to the evaluation and follow-up.
Evaluation and monitoring of different oncological diseases.
Areas of increased metabolic activity and its distribution in the body.
We want you to know what to expect before, during, and after your study. Our team will guide you and accompany you at every stage.
We provide a pre-consultation with our in-house physician in where we understand your case and give you the specific instructions you must follow.
Our team will accompany you throughout the procedure and explain each step so that you will know what to expect.
The images will be analyzed by our specialist team and you will receive the report corresponding to continue your medical evaluation.
It is a study that combines information on metabolic and anatomic for a more complete assessment of different processes in the body.
Each study uses a radiopharmaceutical different and has specific applications. FAN is mainly used in neuroendocrine tumors, FDG pet in the evaluation of different types of cancer and PSMA mainly in prostate cancer.
The type of PET/CT depends on your clinical condition and the indication of your doctor. Our team will review the information required at the time of coordinating the study.
Yes. The preparation varies according to the type of PET/CT. To coordinate your appointment you will receive specific instructions that you must follow.
The study does not usually cause pain. During the procedure is administered radiopharmaceutical and then you should stay in the correct position to obtain the images.
It is important to communicate to the team any medical information that is relevant and follow the directions provided for your type of PET/CT. If you are pregnant, suspect you might be pregnant or you are breastfeeding, you must notify them before the test.
We are here to guide you and accompany you during the whole process.
Agenda your studio and receive the information necessary for your preparation.